Chronic vagus nerve stimulation in patients with heart failure: challenge or failed translation?
Authors:
Open Access
- 18 July 2023
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 10, 1052471
Abstract
Autonomic imbalance between the sympathetic and parasympathetic nervous systems contributes to the progression of chronic heart failure (HF). Preclinical studies have demonstrated that various neuromodulation strategies may exert beneficial cardioprotective effects in preclinical models of HF. Based on these encouraging experimental data, vagus nerve stimulation (VNS) has been assessed in patients with HF with a reduced ejection fraction. Nevertheless, the main trials conducted thus far have yielded conflicting findings, questioning the clinical efficacy of VNS in this context. This review will therefore focus on the role of the autonomic nervous system in HF pathophysiology and VNS therapy, highlighting the potential reasons behind the discrepancy between preclinical and clinical studies.Keywords
Funding Information
- National Natural Science Foundation of China (81800302)
This publication has 93 references indexed in Scilit:
- Angiotensin II stimulates sympathetic neurotransmission to adipose tissuePhysiological Reports, 2013
- Transcutaneous vagus nerve stimulation (t‐VNS) in pharmacoresistant epilepsies: A proof of concept trialEpilepsia, 2012
- Continuous Low-Level Vagus Nerve Stimulation Reduces Stellate Ganglion Nerve Activity and Paroxysmal Atrial Tachyarrhythmias in Ambulatory CaninesCirculation, 2011
- Acetylcholine inhibits hypoxia‐induced tumor necrosis factor‐α production via regulation of MAPKs phosphorylation in cardiomyocytesJournal of Cellular Physiology, 2010
- Chronic Vagus Nerve Stimulation Improves Autonomic Control and Attenuates Systemic Inflammation and Heart Failure Progression in a Canine High-Rate Pacing ModelCirculation: Heart Failure, 2009
- Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemiaProceedings of the National Academy of Sciences, 2008
- Closure of ASD: what aggravates the migrainous diathesis?European Heart Journal, 2006
- Angiotensin II as a cardiovascular risk factorJournal of Human Hypertension, 2002
- Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarctionThe Lancet, 1998
- Effects of Vagal Blockade on Neurohumoral Systems in Conscious Dogs with Heart FailureJournal of Cardiovascular Pharmacology, 1990